13-Cis Retinoic Acid With or Without Vitamin E for Prevention of Lung Cancer
Status:
Completed
Trial end date:
2005-12-01
Target enrollment:
Participant gender:
Summary
RATIONALE: 13 Cis retinoic acid may prevent the development of cancer cells.
PURPOSE: Randomized double-blinded phase II trial to study the effectiveness of 13-cis
retinoic acid with or without vitamin E for chemoprevention or observation of cancer in
persons at high risk of developing lung cancer.
Phase:
Phase 2
Details
Lead Sponsor:
University of Colorado, Denver
Treatments:
alpha-Tocopherol Isotretinoin Tocopherols Tocotrienols Tretinoin Vitamin E Vitamins